Status:
RECRUITING
Optimal Number of Pleural Biopsies During Pleuroscopy
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Pleural Diseases
Eligibility:
All Genders
18+ years
Brief Summary
A single-center, non-randomized, prospective observational, pilot study designed to determine what is the optimal number of pleural biopsies to take during pleuroscopy.
Detailed Description
After enrollment, participants will undergo pleural biopsies via pleuroscopy. Specimens will be divided into three aliquots (1-3, 4-6, 7-10), which will be sent to pathology. A designated pathologist ...
Eligibility Criteria
Inclusion
- Consecutive patients who require pleuroscopies will be enrolled to the study.
- Age ≥ 18
Exclusion
- \- Inability to provide informed consent
Key Trial Info
Start Date :
December 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06897878
Start Date
December 5 2024
End Date
December 1 2025
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
New York, New York, United States, 10028